Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sanosil Biotech is an India-based private company that manufactures and markets commercial disinfection and fumigation products, primarily under the Virosil brand. The company focuses on eco-friendly hydrogen peroxide- and silver-based formulations for aerial, surface, water, pipeline, equipment, and room disinfection across pharmaceutical manufacturing, hospitals, research labs, food and beverage processing, and related hygiene-sensitive industries. Its offerings are positioned as alternatives to chlorine- and formalin-based disinfection approaches, with a particular emphasis on sterile-area fumigation and rapid turnaround times. Sanosil Biotech appears to be an operating commercial supplier rather than a drug-development biotech, and its business is centered on infection-control products and industrial hygiene solutions rather than therapeutic pipelines.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sanosil Biotech.